Meeder Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $78.3K | Buy |
2,789
+1,581
| +131% | +$42.1K | ﹤0.01% | 397 |
|
|
2025
Q4 | $30.1K | Sell |
1,208
-25
| -2% | -$630 | ﹤0.01% | 476 |
|
|
2025
Q3 | $31.4K | Sell |
1,233
-28
| -2% | -$691 | ﹤0.01% | 362 |
|
|
2025
Q2 | $30.6K | Buy |
1,261
+250
| +25% | +$5.83K | ﹤0.01% | 449 |
|
|
2025
Q1 | $25.6K | Sell |
1,011
-536
| -35% | -$14K | ﹤0.01% | 497 |
|
|
2024
Q4 | $41K | Sell |
1,547
-34
| -2% | -$922 | ﹤0.01% | 399 |
|
|
2024
Q3 | $45.8K | Sell |
1,581
-3,480
| -69% | -$102K | ﹤0.01% | 377 |
|
|
2024
Q2 | $142K | Sell |
5,061
-49,576
| -91% | -$1.36M | 0.01% | 231 |
|
|
2024
Q1 | $1.52M | Buy |
54,637
+881
| +2% | +$24.4K | 0.1% | 140 |
|
|
2023
Q4 | $1.55M | Sell |
53,756
-81,747
| -60% | -$2.47M | 0.12% | 130 |
|
|
2023
Q3 | $4.49M | Buy |
135,503
+423
| +0.3% | +$15K | 0.35% | 70 |
|
|
2023
Q2 | $4.95M | Buy |
135,080
+147
| +0.1% | +$5.72K | 0.36% | 65 |
|
|
2023
Q1 | $5.51M | Sell |
134,933
-2,424
| -2% | -$105K | 0.44% | 58 |
|
|
2022
Q4 | $7.04M | Sell |
137,357
-63,063
| -31% | -$3.02M | 0.62% | 32 |
|
|
2022
Q3 | $8.77M | Sell |
200,420
-2,189
| -1% | -$106K | 0.51% | 41 |
|
|
2022
Q2 | $10.6M | Buy |
202,609
+3,660
| +2% | +$187K | 0.62% | 33 |
|
|
2022
Q1 | $10.3M | Buy |
+198,949
| New | +$10.3M | 0.5% | 44 |
|
|
2021
Q4 | – | Sell |
-282,198
| Closed | -$12.1M | – | 2010 |
|
|
2021
Q3 | $12.1M | Buy |
282,198
+2,815
| +1% | +$125K | 0.64% | 29 |
|
|
2021
Q2 | $10.9M | Buy |
279,383
+4,956
| +2% | +$193K | 0.51% | 41 |
|
|
2021
Q1 | $9.94M | Buy |
274,427
+236,391
| +621% | +$8.39M | 0.51% | 41 |
|
|
2020
Q4 | $1.4M | Sell |
38,036
-240,703
| -86% | -$8.83M | 0.31% | 66 |
|
|
2020
Q3 | $9.71M | Buy |
278,739
+5,181
| +2% | +$182K | 0.63% | 33 |
|
|
2020
Q2 | $8.49M | Buy |
273,558
+5,436
| +2% | +$185K | 0.55% | 42 |
|
|
2020
Q1 | $8.3M | Sell |
268,122
-75,728
| -22% | -$2.58M | 0.65% | 29 |
|
|
2019
Q4 | $12.8M | Sell |
343,850
-2,317
| -0.7% | -$82.5K | 0.78% | 25 |
|
|
2019
Q3 | $11.8M | Sell |
346,167
-5,094
| -1% | -$185K | 0.78% | 22 |
|
|
2019
Q2 | $14.4M | Buy |
351,261
+10,889
| +3% | +$432K | 1.01% | 15 |
|
|
2019
Q1 | $13.7M | Sell |
340,372
-850
| -0.2% | -$34K | 1.08% | 13 |
|
|
2018
Q4 | $14.1M | Buy |
341,222
+6,900
| +2% | +$286K | 1.26% | 9 |
|
|
2018
Q3 | $14M | Buy |
334,322
+25,669
| +8% | +$988K | 1.05% | 16 |
|
|
2018
Q2 | $10.6M | Buy |
308,653
+132,671
| +75% | +$4.53M | 0.92% | 17 |
|
|
2018
Q1 | $5.92M | Buy |
175,982
+112,569
| +178% | +$3.87M | 0.55% | 42 |
|
|
2017
Q4 | $2.18M | Buy |
63,413
+4,994
| +9% | +$170K | 0.19% | 121 |
|
|
2017
Q3 | $1.98M | Sell |
58,419
-52,622
| -47% | -$1.69M | 0.22% | 125 |
|
|
2017
Q2 | $3.54M | Sell |
111,041
-47,419
| -30% | -$1.5M | 0.34% | 80 |
|
|
2017
Q1 | $5.14M | Sell |
158,460
-27,011
| -15% | -$852K | 0.46% | 57 |
|
|
2016
Q4 | $5.72M | Sell |
185,471
-89,785
| -33% | -$2.74M | 0.55% | 45 |
|
|
2016
Q3 | $8.85M | Buy |
275,256
+31,414
| +13% | +$1.05M | 0.75% | 17 |
|
|
2016
Q2 | $8.14M | Sell |
243,842
-46,795
| -16% | -$1.49M | 0.76% | 22 |
|
|
2016
Q1 | $8.17M | Sell |
290,637
-116,548
| -29% | -$3.33M | 0.77% | 24 |
|
|
2015
Q4 | $12.5M | Buy |
407,185
+66,256
| +19% | +$2.08M | 1.13% | 14 |
|
|
2015
Q3 | $10.2M | Buy |
340,929
+104,338
| +44% | +$3.35M | 0.99% | 11 |
|
|
2015
Q2 | $7.53M | Sell |
236,591
-13,253
| -5% | -$432K | 0.76% | 20 |
|
|
2015
Q1 | $8.25M | Sell |
249,844
-29,840
| -11% | -$949K | 0.88% | 14 |
|
|
2014
Q4 | $8.27M | Buy |
279,684
+21,521
| +8% | +$617K | 1.05% | 15 |
|
|
2014
Q3 | $7.24M | Sell |
258,163
-118,085
| -31% | -$3.31M | 1.06% | 26 |
|
|
2014
Q2 | $10.6M | Buy |
376,248
+108,414
| +40% | +$3.09M | 1.57% | 9 |
|
|
2014
Q1 | $8.16M | Buy |
267,834
+248,249
| +1,268% | +$7.4M | 1.34% | 18 |
|
|
2013
Q4 | $569K | Sell |
19,585
-1,184
| -6% | -$34.5K | 0.1% | 164 |
|
|
2013
Q3 | $566K | Buy |
20,769
+869
| +4% | +$23.6K | 0.11% | 146 |
|
|
2013
Q2 | $529K | Buy |
+19,900
| New | +$550K | 0.11% | 148 |
|
Other funds holding PFE
VCM
VPM
Meeder Asset Management's PFE Position: Q1 2026 in Review
Meeder Asset Management increased its Pfizer (PFE) stake by 131% in Q1 2026, buying an estimated $42.1K and bringing the position to 2,789 shares worth $78.3K. The position accounts for ﹤0.01% of the portfolio, ranked #397.
Meeder Asset Management first reported a position in PFE in Q2 2013 and has held it in 51 quarters since. The position peaked at $14.4M in Q2 2019. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Meeder Asset Management held 2,789 shares of Pfizer worth $78.3K as of Q1 2026.
- Meeder Asset Management bought 1,581 Pfizer shares in Q1 2026, an estimated $42.1K.
- Pfizer made up ﹤0.01% of Meeder Asset Management's portfolio in Q1 2026, its #397 holding.
- Meeder Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 51 quarters since.
- Meeder Asset Management's Pfizer position peaked at $14.4M in Q2 2019.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Meeder Asset Management's 13F filing for Q1 2026, filed 7 May 2026.